SCHEMBL17366239

SCHEMBL17366239

Fc1cc(OCI)ccc1Br

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NSD2 O96028 1/20 0.41
NSD3 Q9BZ95 1/20 0.41
SLC6A4 P31645 1/20 0.39
EGFR P00533 1/20 0.38
KDR P35968 1/20 0.38
KDM1A O60341 3/20 0.34
KCNH2 Q12809 2/20 0.34
KDM1B Q8NB78 1/20 0.34
MAOB P27338 4/20 0.33
PARP15 Q460N3 1/20 0.33
PARP10 Q53GL7 1/20 0.33
AOC3 Q16853 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MCHR1 Q99705 1/20 0.31
RCOR1 Q9UKL0 1/20 0.31
KIF11 P52732 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14047256 0.85 NSD2 (0.45) NSD2NSD3SLC6A4EGFRKDR
SCHEMBL15806741 0.82 EGFR (0.42) NSD2NSD3SLC6A4EGFRKDR
SCHEMBL1509936 0.80 NQO1 (0.50) NSD2NSD3SLC6A4EGFRKDR
SCHEMBL7912630 0.78 NSD2 (0.46) NSD2NSD3SLC6A4EGFRKDR
SCHEMBL25299247 0.78 NSD2 (0.46) NSD2NSD3SLC6A4EGFRKDR
SCHEMBL2171833 0.77 EGFR (0.43) NSD2NSD3SLC6A4EGFRKDR
SCHEMBL1777505 0.77 NSD2 (0.45) NSD2NSD3SLC6A4EGFRKDR
SCHEMBL23414843 0.77 KDM4E (0.45) NSD2NSD3SLC6A4EGFRKDR
SCHEMBL15300658 0.77 NSD2 (0.45) NSD2NSD3SLC6A4EGFRKDR
SCHEMBL29972592 0.77 KDM4E (0.45) NSD2NSD3SLC6A4EGFRKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2588451-B1 PIPERIDINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS BOEHRINGER INGELHEIM INT (DE) 2015-12-30 EP disclosed